Simplified artesunate regimen is non-inferior to WHO-recommended malaria treatment

In African children, a 3-dose intramuscular artesunate regimen is non-inferior to the WHO-recommended regimen for the treatment of severe malaria, according to a trial. The trial did not show non-inferiority of a similar 3-dose intravenous regimen.